Zhu, X.D.

screening cancer prostate prostate cancer study mortality interval erspc control arm rotterdam trial biopsy control european randomized study european death antigen result diagnosis randomized roobol follow-up group escape pc-speci fic mortality detection schroder survival screening arm prostate-speci fic antigen incidence number round treatment analysis prostate-speci pca mortality schroder fh urology screening interval model reduction table population score screening algorithm cancer screening trial roobol mj prognostic factors effect volume gothenburg gleason interval cancer screening round outcome erspc rotterdam intervention arm value cohort level stage insulator chromatin pc incidence intervention algorithm randomization interaction rectal examination treatment modality netherland pc-speci screen centre 1000 ly disease-specific 2011 european association factor disease-speci fic mortality